Literature DB >> 26272028

A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.

Varun Sethi1, Tarek Yousry2, Nils Muhlert3, Daniel J Tozer4, Daniel Altmann5, Maria Ron1, Claudia Wheeler-Kingshott1, David H Miller6, Declan T Chard6.   

Abstract

BACKGROUND: Cortical grey matter (GM) lesions are common in multiple sclerosis (MS), but little is known about their temporal evolution. We investigated this in people with relapsing-remitting (RR) and secondary progressive (SP) MS.
METHODS: 27 people with RRMS, and 22 with SPMS were included in this study. Phase-sensitive inversion recovery scans were acquired on 2 occasions. Cortical GM lesions were classified as intracortical (IC, only involving GM) and leucocortical (LC, mixed GM-white matter (WM)); WM lesions touching the cortex as juxtacortical (JC). On follow-up scans, new IC, LC and JC lesions were identified, and any change in classification of lesions previously observed was noted. WM lesion counts in the whole brain were assessed on PD/T2-weighted scans.
RESULTS: Over a mean (SD) of 21.0 (5.8) months, the number of new IC lesions per person per year was greater in SPMS (1.6 (1.9)) than RRMS (0.8 (1.9)) (Mann-Whitney p=0.039). All new LC lesions arose from previously seen IC lesions (SPMS 1.4 (1.8) per person per year, and RRMS 1.1 (1.0)), and none arose de novo, or from previously seen JC lesions. Changes in cortical GM (either new IC or IC converting to LC) lesion counts did not correlate with the changes in WM lesion counts.
CONCLUSIONS: New cortical GM lesions rarely arise from the WM and the rate of new IC lesion formation is not closely linked with WM lesion accrual. IC lesion formation appears to be more common in SPMS than RRMS. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26272028     DOI: 10.1136/jnnp-2015-311102

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  8 in total

Review 1.  Insights from Ultrahigh Field Imaging in Multiple Sclerosis.

Authors:  Matthew K Schindler; Pascal Sati; Daniel S Reich
Journal:  Neuroimaging Clin N Am       Date:  2017-01-26       Impact factor: 2.264

2.  Cortical lesion hotspots and association of subpial lesions with disability in multiple sclerosis.

Authors:  Erin S Beck; Josefina Maranzano; Nicholas J Luciano; Prasanna Parvathaneni; Stefano Filippini; Mark Morrison; Daniel J Suto; Tianxia Wu; Peter van Gelderen; Jacco A de Zwart; Samson Antel; Dumitru Fetco; Joan Ohayon; Frances Andrada; Yair Mina; Chevaz Thomas; Steve Jacobson; Jeff Duyn; Irene Cortese; Sridar Narayanan; Govind Nair; Pascal Sati; Daniel S Reich
Journal:  Mult Scler       Date:  2022-02-10       Impact factor: 5.855

3.  The effect of fingolimod on focal and diffuse grey matter damage in active MS patients.

Authors:  Albulena Bajrami; Marco Pitteri; Marco Castellaro; Francesca Pizzini; Chiara Romualdi; Stefania Montemezzi; Salvatore Monaco; Massimiliano Calabrese
Journal:  J Neurol       Date:  2018-06-25       Impact factor: 4.849

4.  Spatial Correlation of Pathology and Perfusion Changes within the Cortex and White Matter in Multiple Sclerosis.

Authors:  A D Mulholland; R Vitorino; S-P Hojjat; A Y Ma; L Zhang; L Lee; T J Carroll; C G Cantrell; C R Figley; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2017-11-02       Impact factor: 3.825

5.  Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI.

Authors:  Constantina A Treaba; Tobias E Granberg; Maria Pia Sormani; Elena Herranz; Russell A Ouellette; Céline Louapre; Jacob A Sloane; Revere P Kinkel; Caterina Mainero
Journal:  Radiology       Date:  2019-04-09       Impact factor: 29.146

6.  Inversion Recovery Susceptibility Weighted Imaging With Enhanced T2 Weighting at 3 T Improves Visualization of Subpial Cortical Multiple Sclerosis Lesions.

Authors:  Erin S Beck; Neville Gai; Stefano Filippini; Josefina Maranzano; Govind Nair; Daniel S Reich
Journal:  Invest Radiol       Date:  2020-11       Impact factor: 10.065

7.  The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.

Authors:  Fawad Yousuf; Gloria Kim; Shahamat Tauhid; Bonnie I Glanz; Renxin Chu; Subhash Tummala; Brian C Healy; Rohit Bakshi
Journal:  Front Neurol       Date:  2016-06-29       Impact factor: 4.003

8.  Clinical significance of cortical lesions in patients with multiple sclerosis: A neuropsychological and neuroimaging study.

Authors:  Futoshi Matsushita; Hirotaka Kida; Ken-Ichi Tabei; Chizuru Nakano; Keita Matsuura; Yuichiro Ii; Ryogen Sasaki; Akira Taniguchi; Yugo Narita; Masayuki Maeda; Masayuki Satoh; Hidekazu Tomimoto
Journal:  Brain Behav       Date:  2018-02-14       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.